A number of Biotech e.g. MSB over 1.2bln Market Cap and not FDA on horizon...
next 2-3 weeks - climb to 40c...45c - starts to sink in..
Post FDA ..expecting a good run 60-100% - 70 to 80c level...
Biggest gainers will be 12months after FDA to $2 or $3 based on Sales trajectory...
Basically : 3% of 3.7mln and 1% of 6.3mln = 174 000 patients - very likely to hit in first 12 -18months...
174 000 patients by 6 refills by usd 500net Revenue ( after sharing with distributors/ pharma / dermatologists) = Solid usd 520mln Net Revenue
15x of that is usd 7.8bln or usd 5.2 per share price...
People whi disagree with Fast rump up - can look at trajectory in Japan and to sleep quite divide my number by 2and still get usd 2.6 per share...
Remember refills and Japan still has 70% new patents every year..
A number of Biotech e.g. MSB over 1.2bln Market Cap and not FDA...
-
- There are more pages in this discussion • 627 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $1.949M | 5.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2985 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 420471 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |